Kurtzberg J - Search Results

1

Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature.

Aguayo A, Cortes JE, Kantarjian HM, Beran M, Gandhi V, Plunkett W, Kurtzberg J, Keating MJ. Aguayo A, et al. Among authors: kurtzberg j. Cancer. 1999 Jan 1;85(1):58-64. Cancer. 1999. PMID: 9921974 Review.

2

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response.

Gandhi V, Plunkett W, Rodriguez CO Jr, Nowak BJ, Du M, Ayres M, Kisor DF, Mitchell BS, Kurtzberg J, Keating MJ. Gandhi V, et al. Among authors: kurtzberg j. J Clin Oncol. 1998 Nov;16(11):3607-15. doi: 10.1200/JCO.1998.16.11.3607. J Clin Oncol. 1998. PMID: 9817282 Clinical Trial.

3

Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies.

Kisor DF, Plunkett W, Kurtzberg J, Mitchell B, Hodge JP, Ernst T, Keating MJ, Gandhi V. Kisor DF, et al. Among authors: kurtzberg j. J Clin Oncol. 2000 Mar;18(5):995-1003. doi: 10.1200/JCO.2000.18.5.995. J Clin Oncol. 2000. PMID: 10694549 Clinical Trial.

4

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.

Kurtzberg J, Ernst TJ, Keating MJ, Gandhi V, Hodge JP, Kisor DF, Lager JJ, Stephens C, Levin J, Krenitsky T, Elion G, Mitchell BS. Kurtzberg J, et al. J Clin Oncol. 2005 May 20;23(15):3396-403. doi: 10.1200/JCO.2005.03.199. J Clin Oncol. 2005. PMID: 15908652 Clinical Trial.

5

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.

Berg SL, Blaney SM, Devidas M, Lampkin TA, Murgo A, Bernstein M, Billett A, Kurtzberg J, Reaman G, Gaynon P, Whitlock J, Krailo M, Harris MB; Children's Oncology Group. Berg SL, et al. Among authors: kurtzberg j. J Clin Oncol. 2005 May 20;23(15):3376-82. doi: 10.1200/JCO.2005.03.426. J Clin Oncol. 2005. PMID: 15908649 Clinical Trial.

6

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

Tubergen DG, Stewart CF, Pratt CB, Zamboni WC, Winick N, Santana VM, Dryer ZA, Kurtzberg J, Bell B, Grier H, Vietti TJ. Tubergen DG, et al. Among authors: kurtzberg j. J Pediatr Hematol Oncol. 1996 Nov;18(4):352-61. doi: 10.1097/00043426-199611000-00004. J Pediatr Hematol Oncol. 1996. PMID: 8888741 Clinical Trial.

7

The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.

Quaranta BP, Halperin EC, Kurtzberg J, Clough R, Martin PL. Quaranta BP, et al. Among authors: kurtzberg j. Cancer. 2004 Aug 15;101(4):845-50. doi: 10.1002/cncr.20413. Cancer. 2004. PMID: 15305418 Free article.

8

S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.

Hershfield MS, Kredich NM, Koller CA, Mitchell BS, Kurtzberg J, Kinney TR, Falletta JM. Hershfield MS, et al. Among authors: kurtzberg j. Cancer Res. 1983 Jul;43(7):3451-8. Cancer Res. 1983. PMID: 6601986

9

A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.

Agrawal NR, Bukowski RM, Rybicki LA, Kurtzberg J, Cohen LJ, Hussein MA. Agrawal NR, et al. Among authors: kurtzberg j. Cancer. 2003 Jul 1;98(1):94-9. doi: 10.1002/cncr.11480. Cancer. 2003. PMID: 12833461 Free article. Clinical Trial.

10

An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.

Ettinger LJ, Kurtzberg J, Voûte PA, Jürgens H, Halpern SL. Ettinger LJ, et al. Among authors: kurtzberg j. Cancer. 1995 Mar 1;75(5):1176-81. doi: 10.1002/1097-0142(19950301)75:5<1176::aid-cncr2820750519>3.0.co;2-y. Cancer. 1995. PMID: 7850718 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters